What changed in this filing

/stocks — the workspaceLOADING

Item 5. Other Information

2021-05-17 compared with 2020-11-06 · 35 added, 32 removed, 11 unchanged (86% of the section changed)

Other Information

Subsequent to September

30, 2020, effective November 6, 2020, the Company entered into a waiver agreement with the holder of the April 2020 Senior

Convertible Note and the August 2020 Senior Secured Convertible Note.

Prior to the waiver agreement, the noteholder had the right,

at any time from and after October 30, 2020, in its sole discretion, to require the Company to redeem all, or any portion, of

the respective convertible notes.

Under the waiver agreement, so long as no event of default has occurred and is continuing under

the convertible notes (unless waived in writing by the holder of the convertible notes), the noteholder waived this redemption

right until November 30, 2020.

Furthermore, the waiver will be automatically extended for additional one-month periods, unless

the noteholder delivers notice to us of an election to terminate the waiver prior to the then-current end date for the waiver.

exhibits filed as part of this Quarterly Report on Form 10-Q are set forth in the “

Exhibit Index ”

to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report

to be signed on its behalf by the undersigned, thereunto duly authorized.

November 6, 2020

to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed

on its behalf by the undersigned, thereunto duly authorized.

and Chief Financial Officer

Financial and Accounting Officer)

Certificate of Amendment to the Certificate of Incorporation dated July 24, 2020.

of Securities Purchase Agreement dated August 6, 2020.

of Senior Convertible Note dated August 6, 2020.

Form of Amended and Restated Security Agreement dated August 6, 2020.

Form of Amended and Restated Guaranty dated August 6, 2020.

Certification

of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Certification

of Principal Financial and Accounting Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Certification

of Principal Executive Officer pursuant to 18 U.S.C.

Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley

Certification

of Principal Financial and Accounting Officer pursuant to 18 U.S.C.

Section 1350, as adopted pursuant to Section 906 of the

Sarbanes-Oxley Act of 2002.

Certificate of Incorporation (1)

Certificate of Amendment to Certificate of Incorporation (1)

Certificate of Amendment to Certificate of Incorporation, dated October 1, 2018 (6)

Certificate of Amendment to Certificate of Incorporation, dated June 26, 2019 (7)

Certificate of Amendment to Certificate of Incorporation, dated July 24, 2020 (10)

Form of Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock (8)

Certificate of Elimination - Series A Convertible Preferred Stock and Series A-1 Convertible Preferred Stock (4)

Amended and Restated Bylaws (9)

Specimen PAVmed Inc.

Common Stock Certificate (1)

Specimen PAVmed Inc.

Series W Warrant Certificate (1)

Series W Warrant Agreement, dated April 28, 2016, between Continental Stock Transfer & Trust Company and the Registrant (2)

Specimen PAVmed Inc.

Series Z Warrant Certificate (3)

Amended and Restated Series Z Warrant Agreement, dated as of June 8, 2018, by and between PAVmed Inc.

and Continental Stock Transfer & Trust Company, as Warrant Agent (5)

Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Certification of Principal Financial and Accounting Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Certification of Principal Executive Officer pursuant to 18 U.S.C.

Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

Certification of Principal Financial and Accounting Officer pursuant to 18 U.S.C.

Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

Instance Document

4 unchanged sentences

Taxonomy Extension Presentation Linkbase

by reference to the Current Report on Form 8-K filed by the Company on July 27, 2020.

by reference to the Current Report on Form 8-K filed by the Company on August 6, 2020.

by reference to the Registrant’s Registration Statement on Form S-1 - SEC File No.

by reference to the Registrant’s Current Report on Form 8-K filed May 3, 2016.

by reference to the Registrant’s Current Report on Form 8-K filed April 5, 2018.

by reference to the Registrant’s Current Report on Form 8-K/A filed April 20, 2018.

by reference to the Registrant’s Current Report on Form 8-K filed June 8, 2018.

by reference to the Registrant’s Current Report on Form 8-K filed October 2, 2018.

by reference to the Registrant’s Definitive Proxy Statement on Schedule 14A filed April 30, 2019

by reference to the Registrant’s Current Report on Form 8-K filed June 27, 2019.

by reference to the Registrant’s Current Report on Form 8-K filed January 15, 2021.

by reference to the Registrant’s Definitive Proxy Statement on Schedule 14A filed June 11, 2020

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 5. Other Information